In a move that has sparked global concern and heated debate, the United States has officially severed its decades-long relationship with the World Health Organization (WHO), marking the end of a 78-year partnership. But here’s where it gets controversial: while the withdrawal was finalized on January 22, 2026, the U.S. still owes the WHO over $130 million in unpaid dues, leaving many to question the ethics and practicality of this decision. And this is the part most people miss: the U.S. exit isn’t just a political statement—it could have far-reaching consequences for global health, from weakening pandemic responses to hindering vaccine development.
The WHO, a specialized agency of the United Nations, plays a critical role in coordinating global health efforts, from tackling outbreaks like Ebola and polio to providing essential resources to low-income countries. The U.S., historically one of the WHO’s largest donors, contributed hundreds of millions of dollars annually and supplied experts to support its mission. So, why the sudden departure? Former President Donald Trump cited the WHO’s mishandling of the COVID-19 pandemic, its failure to implement reforms, and its perceived political biases as reasons for the withdrawal. But is this a fair assessment? While the WHO did make costly errors during the pandemic—such as initially advising against masks and delaying acknowledgment of airborne COVID-19 transmission—critics argue that these missteps don’t justify abandoning a vital global health institution.
Another point of contention? The Trump administration’s frustration that no American has ever led the WHO since its inception in 1948. Is this a legitimate grievance or an overreaction? Given the U.S.’s substantial financial contributions, some argue it’s unfair, while others counter that leadership should be based on merit, not nationality.
Experts like Lawrence Gostin, a public health law expert at Georgetown University, warn that the U.S. withdrawal could cripple global health initiatives. From polio eradication to maternal health programs, the absence of U.S. expertise and funding could leave the world more vulnerable to future health crises. Gostin bluntly calls it “the most ruinous Presidential decision in my lifetime.” Similarly, Dr. Ronald Nahass, president of the Infectious Diseases Society of America, labels the move “shortsighted, misguided, and scientifically reckless.”
One immediate consequence? The U.S. is no longer part of critical WHO committees, including those that track flu strains and guide vaccine updates. This loss of access to global health data could leave Americans less prepared for future outbreaks. Trump administration officials claim they’ll bypass the WHO by forming direct health partnerships with other countries. But is this realistic? Gostin doubts the U.S. can secure agreements with more than a dozen nations, especially when key players like China or countries affected by U.S. tariffs are unlikely to cooperate. “The claim is almost laughable,” he notes.
Adding to the controversy, Gostin argues that Trump overstepped his authority by withdrawing without congressional approval. While the U.S. gave the required one-year notice, it failed to settle its financial obligations, leaving a $133 million debt. An administration official disputes this, claiming no payment was required before withdrawal. Who’s right? And what does this say about the U.S.’s commitment to global cooperation?
As the dust settles, one question remains: Will the U.S.’s departure from the WHO ultimately harm global health—or is this a necessary step toward reform? Weigh in below—do you think the U.S. made the right call, or is this a dangerous gamble with global consequences?
